Actively Recruiting
PET-guided Radiotherapy for Patients With Small Cell Lung Cancer.
Led by University Hospital, Essen · Updated on 2024-09-27
30
Participants Needed
1
Research Sites
278 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
There is a prospective risk-adapted evaluation of the optimal dose of radiotherapy for definitive radiotherapy of locally advanced small cell lung cancer within the corridor recommended as standard therapy according to the current interdisciplinary S3 guideline of the German Cancer Society/Cancer Aid/AWMF
CONDITIONS
Official Title
PET-guided Radiotherapy for Patients With Small Cell Lung Cancer.
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Histopathologic confirmation of small cell lung cancer
- Limited disease stage of small cell lung cancer
You will not qualify if you...
- Cancer histology other than small cell lung cancer
- Presence of another tumor diagnosis
- ECOG performance status 3 or worse
- Extensive disease stage
- Stage IV lung cancer
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
University Hospital Essen
Essen, Germany
Actively Recruiting
Research Team
M
Maja Guberina
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
0
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here